Allegory Venture Partners expects to make venture capital investments in emerging stage life sciences companies engaged in development of products that are poised to improve efficiencies, advance capabilities and/or provide cost-effective solutions in the healthcare and life sciences sector. It currently intends to build a portfolio of enterprises each with unique and valuable product opportunities, exceptional management teams, and clear, achievable paths to market and profitability. Moreover, Allegory Venture Partners' relationships with entities that are potential acquirers of new life sciences technologies and services inform the firm's investment process.
The Allegory Venture Partners team also seeks to identify and foster the formation and development of enterprises that are poised to disrupt -- such products or services may address an existing market from a new angle or may create entirely new markets. Using its collection of analytical tools developed and refined by its partners throughout their careers, Allegory Venture Partners expects to invest in innovations that are likely to create new market opportunities or serve otherwise underserved consumers.